Vascular Drugs

71 drugs

Quick-reference dosing for 71 vascular medicines, aligned to current UK formularies. Each entry lists adult, paediatric and (where relevant) neonatal doses, renal and hepatic adjustments, contraindications, key interactions, monitoring and clinical pearls — with the source reference. Always confirm doses against current prescribing references before prescribing.

Alirocumab (PCSK9 Inhibitor — Post-ACS)

PCSK9 Inhibitor (Human Monoclonal Antibody)
Alprostadil (PGE1)

Prostaglandin E1
Alteplase (Peripheral Arterial / DVT Use)

Thrombolytic — Catheter-Directed Thrombolysis / Peripheral Arterial Occlusion
Ambrisentan

Selective Endothelin-A Receptor Antagonist — Pulmonary Arterial Hypertension
Aminocaproic Acid

Antifibrinolytic — Surgical Haemostasis (Alternative to Tranexamic Acid)
Amlodipine

Dihydropyridine Calcium Channel Blocker — Raynaud's / Peripheral Vascular Disease / Hypertension
Apixaban

Direct Oral Factor Xa Inhibitor — VTE / AF Stroke Prevention
Argatroban

Direct Thrombin Inhibitor — HIT
Aspirin (Antiplatelet)

Antiplatelet — COX Inhibitor
Atorvastatin

HMG-CoA Reductase Inhibitor (Statin)
Betrixaban (Extended VTE Prophylaxis — Medical Patients)

Oral Factor Xa Inhibitor (DOAC — Extended Duration)
Bivalirudin

Direct Thrombin Inhibitor — HIT / Endovascular Procedures
Bosentan

Endothelin Receptor Antagonist (ERA) — Pulmonary Arterial Hypertension / Digital Ulcers
Canakinumab (IL-1β Inhibitor — Post-MI CV Prevention)

IL-1β Monoclonal Antibody (Anti-Inflammatory CV Agent)
Cangrelor (IV P2Y12 Inhibitor — Acute PCI)

Intravenous P2Y12 ADP Receptor Antagonist (Direct-Acting, Reversible)
Cilostazol

Phosphodiesterase type 3 inhibitor / antiplatelet
Cilostazol

Phosphodiesterase-3 Inhibitor (Antiplatelet/Vasodilator)
Clopidogrel

Antiplatelet (P2Y12 ADP receptor antagonist)
Colchicine (Cardiovascular Anti-Inflammatory)

Anti-Inflammatory — NLRP3 Inflammasome Inhibitor (Cardiovascular Indication)
Dabigatran

Direct Oral Thrombin Inhibitor — VTE / AF Stroke Prevention
Dalteparin

Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
Desmopressin (DDAVP)

Vasopressin Analogue — Haemostasis / Haemophilia A / vWD
Dipyridamole (Secondary Stroke Prevention)

Antiplatelet — Phosphodiesterase Inhibitor / Adenosine Uptake Inhibitor
Doxazosin

Alpha-1 Adrenoceptor Antagonist — Hypertension / Raynaud's / BPH
Edoxaban (VTE Treatment/PE — Vascular)

Direct Factor Xa Inhibitor (DOAC)
Enoxaparin (Vascular)

Low Molecular Weight Heparin
Epoprostenol

Prostacyclin (PGI2) — Severe Pulmonary Arterial Hypertension
Eptifibatide (GPIIb/IIIa Inhibitor — ACS/PCI)

GPIIb/IIIa Receptor Antagonist (Cyclic Peptide)
Fondaparinux

Indirect Factor Xa Inhibitor — VTE Prophylaxis / Treatment
Glyceryl Trinitrate (IV)

Organic Nitrate (IV)
Hydralazine

Direct-Acting Vasodilator — Hypertensive Emergency / Chronic Hypertension
Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction)

Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
Iloprost (IV/Inhaled)

Prostacyclin Analogue
Iloprost (IV/Nebulised)

Prostacyclin analogue (vasodilator)
Inositol nicotinate

Peripheral vasodilator
Isosorbide Mononitrate

Organic Nitrate
Losartan

Angiotensin II Receptor Blocker (ARB) — Hypertension / Raynaud's / Marfan Syndrome
Macitentan

Endothelin Receptor Antagonist (ERA) — Pulmonary Arterial Hypertension
Naftidrofuryl oxalate

Vasodilator
Naftidrofuryl Oxalate

5-HT2 Receptor Antagonist — Peripheral Arterial Disease (Intermittent Claudication)
Nifedipine (Modified-release)

Dihydropyridine calcium channel blocker
Nifedipine (Raynaud's)

Calcium Channel Blocker (Dihydropyridine)
Oxerutins

Bioflavonoid (rutin)
Pentoxifylline

Hemorheological Agent (Methylxanthine)
Pentoxifylline (Oxpentifylline)

Haemorrheological agent (xanthine derivative)
Phenoxybenzamine

Irreversible Non-Selective Alpha Adrenoceptor Antagonist — Phaeochromocytoma Pre-operative Preparation
Phentolamine

Non-Selective Alpha Adrenoceptor Antagonist — Vasopressor Extravasation / Phaeochromocytoma
Prasugrel (P2Y12 Antiplatelet — ACS/PCI)

P2Y12 ADP Receptor Antagonist (Thienopyridine Prodrug)
Prazosin

Alpha-1 Adrenoceptor Antagonist — Raynaud's Phenomenon / Hypertension
Protamine Sulphate

Heparin Antidote — Vascular / Cardiac Surgery
Ramipril

ACE Inhibitor
Riociguat

Soluble Guanylate Cyclase (sGC) Stimulator — PAH / CTEPH
Rivaroxaban

Direct Oral Factor Xa Inhibitor — VTE / PAD / AF Stroke Prevention
Selexipag

Prostacyclin Receptor (IP Receptor) Agonist — Pulmonary Arterial Hypertension
Sildenafil

PDE5 Inhibitor — Pulmonary Arterial Hypertension / Raynaud's Phenomenon
Sodium Nitroprusside

Direct Vasodilator (NO Donor) — Hypertensive Emergency / Aortic Dissection
Sodium tetradecyl sulfate

Sclerosant
Streptokinase

Thrombolytic — Peripheral Arterial Occlusion / DVT (Historical)
Tenecteplase (TNK-tPA — STEMI/Massive PE)

Fibrin-Specific Thrombolytic (Third-Generation tPA)
Terlipressin

Vasopressin analogue / vasopressor
Terlipressin (Vascular)

Vasopressin Analogue
Ticagrelor

Antiplatelet (reversible P2Y12 inhibitor)
Tinzaparin

Low Molecular Weight Heparin — VTE Treatment / Prophylaxis
Tirofiban (GPIIb/IIIa Inhibitor — ACS/PCI)

GPIIb/IIIa Receptor Antagonist (Non-Peptide Mimetic)
Tranexamic Acid

Antifibrinolytic — Vascular / Surgical Haemostasis
Treprostinil

Prostacyclin Analogue — Pulmonary Arterial Hypertension / Digital Ulcers
Unfractionated Heparin (IV)

Anticoagulant — Indirect Thrombin Inhibitor
Unfractionated Heparin (Peripheral/Central Line Flush)

Anticoagulant flush / catheter maintenance
Urokinase

Thrombolytic — Catheter-Directed Thrombolysis / Catheter Occlusion
Vorapaxar

PAR-1 (Protease-Activated Receptor-1) Antagonist — Secondary Prevention in PAD / MI
Warfarin

Vitamin K Antagonist